Article
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma
12 Jan 2018
Abstract excerpt
OBJECTIVEDexamethasone, a known regulator of mesenchymal programming in glioblastoma (GBM), is routinely used to manage edema in GBM patients. Dexamethasone also activates the expression of genes, such as CEBPB, in GBM stem cells (GSCs). However, the drug's impact on invasion, proliferation, and angiogenesis in GBM remains unclear. To determine whether dexamethasone induces invasion, proliferation, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
